吡嗪酰胺
结核分枝杆菌
肺结核
药品
微生物学
化学
医学
生物
药理学
病理
作者
Isabella Letícia Esteves Barros,Jean Eduardo Meneguello,Luciana Dias Ghiraldi-Lopes,Glaucia Sayuri Arita,João Vitor de Oliveira Silva,Katiany Rizzieri Caleffi Ferracioli,Regiane Bertin de Lima Scodro,Vera Lúcia Dias Siqueira,Eduardo Jorge Pilau,Paula Aline Zanetti Campanerut-Sá,Rosilene Fressatti Cardoso
标识
DOI:10.2217/fmb-2020-0307
摘要
Background: Pyrazinamide (PZA) represents a milestone as a first-line antituberculosis drug due to its sterilizing activity against Mycobacterium tuberculosis. Materials & Methods: The protein changes induced by subinhibitory PZA exposure of M. tuberculosis in acidic pH were evaluated by a proteomic approach. Results: Among the 1059 M. tuberculosis proteins identified, the specific acidification in the culture medium induced the over-representation of MurF (Rv2157c), and its underrepresentation was induced by 12 h of PZA exposure. PanB (Rv2225) was over-represented at 24 h of PZA exposure. Conclusion: The authors highlight the over-representation of PanB in M. tuberculosis correlates of PZA action in acidic pH, reinforcing the role of the pantothenate pathway as a bacillus drug target to be explored.
科研通智能强力驱动
Strongly Powered by AbleSci AI